Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Methylnaltrexone for OIC in Cancer Pain
NCT00858754Phase 4Withdrawn
- Sponsor
- Valeant Pharmaceuticals
- Start
- Mar 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Valeant Pharmaceuticals. Planned start Mar 2009; status: withdrawn.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00858754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858754.